SCHEMBL7996949

SCHEMBL7996949

COc1ccccc1N1CCN(Cc2c[nH]c(-c3ccc4c(c3)CCO4)n2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 1/20 0.47
DRD2 P14416 10/20 0.47
DRD4 P21917 10/20 0.47
DRD3 P35462 9/20 0.47
GAA P10253 2/20 0.45
HTR1A P08908 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
MAPT P10636 2/20 0.44
PKM P14618 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HRH2 P25021 1/20 0.43
HRH1 P35367 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7979110 0.91 DRD4 (0.46) DRD2DRD4DRD3ADRA1DADRA1A
Hydrochloric Acid SCHEMBL7991375 0.91 DRD4 (0.45) DRD2DRD4DRD3HTR1AADRA1D
SCHEMBL7993833 0.88 LMNA (0.41) DRD2DRD4DRD3GAAMAPT
Bromide SCHEMBL7991351 0.88 LMNA (0.41) DRD2DRD4DRD3GAAMAPT
SCHEMBL7997014 0.87 HTR7 (0.44) PTK2DRD2DRD4DRD3ALDH1A1
SCHEMBL7979506 0.86 ABCB1 (0.52) DRD2DRD4DRD3GAAHTR1A
Bromide SCHEMBL8218997 0.86 HTR7 (0.43) PTK2DRD2DRD4DRD3ALDH1A1
Bromide SCHEMBL7993380 0.86 ABCB1 (0.51) DRD2DRD4DRD3GAAHTR1A
SCHEMBL7990254 0.85 KDM4E (0.41) GAAMAPTALDH1A1KDM4ELMNA
SCHEMBL7991687 0.84 DRD2 (0.43) DRD2DRD4DRD3GAAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288230-B1 COMPOUNDS FOR TREATMENT OF PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION 2001-09-11 US claimed
US-6288230-B1 COMPOUNDS FOR TREATMENT OF PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION 2001-09-11 US disclosed
WO-2000018763-A2 2-(2,3-DIHYDROBENZOFURAN-5-YL)-4-AMINOMETHYLIMIDAZOLES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed